Impact of socioeconomic geography on outcomes following hospital discharge for people with diabetes




Diabetes, Socioeconomic, Readmission, Hospital Discharge


Background: Socioeconomic factors drive poor diabetes outcomes. Little research has assessed the impact of socio-economic factors on outcomes when people with diabetes are discharged from hospital. We evaluate the impact of socioeconomic factors on readmission and mortality.

Methods: We performed a retrospective evaluation of data extracted from an electronic health record of a large UK hospital for all patients discharged with a diabetes diagnosis over 3 years. Data were extracted for 46,357 distinct discharges and matched at patient level to postcode sector socioeconomic data. Outcomes were evaluated against pre-specified diabetes cohorts. Standardised effect sizes were calculated.

Results: Socioeconomic status was statistically significantly associated with 14 of 19 socioeconomic variables in relation to 180-day mortality for a type 2 diabetes mellitus (T2DM) patient cohort; no statistically significant association between mortality and socioeconomic variables in a type 1 diabetes mellitus (T1DM) cohort was noted. Socioeconomic status was significantly associated with one of 19 variables for 28-day readmission in T2DM patient cohorts compared with nine statistically significant variables for T1DM cohorts. Effect sizes were strongest for deprivation indices (Cohen’s D=0.29) and health-related activity impairment (Cohen’s D=0.15).

Conclusion: There is a strong association between geographical socioeconomic status and readmission outcomes for patients with T1DM but only a limited association with mortality. In contrast, mortality for T2DM cohorts is strongly associated with socioeconomic status whilst readmission is not.


NHS Digital. National Diabetes Inpatient Audit (NaDIA) – 2017. Available at:

Umpierrez GE, Isaacs SD, Bazargan N, et al. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002;87(3):978–82.

Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clinic Proc 2003;78(12):1471–8.

Rubin DJ. Hospital readmission of patients with diabetes. Curr Diab Rep 2015;15(4):17.

Ostling S, Wyckoff J, Ciarkowski SL, et al. The relationship between diabetes mellitus and 30-day readmission rates. Clin Diabetes Endocrinol 2017; 3(1):3.

Sarma S, Mentz RJ, Kwasny MJ, et al. Association between diabetes mellitus and post‐discharge outcomes in patients hospitalized with heart failure: findings from the EVEREST trial. Eur J Heart Failure 2013;15(2):194–202.

Laskey WK, Selzer F, Vlachos HA, et al. Comparison of in-hospital and one-year outcomes in patients with and without diabetes mellitus undergoing percutaneous catheter intervention (from the National Heart, Lung, and Blood Institute Dynamic Registry). Am J Cardiol 2002;90(10):1062–7.

Sonmez H, Kambo V, Avtanski D, Lutsky L, Poretsky L. The readmission rates in patients with versus those without diabetes mellitus at an urban teaching hospital. J Diabetes Complications 2017;31(12):1681–5.

Kerr M. Inpatient care for people with diabetes: the economic case for change. NHS Diabetes UK. 2011.

Targher G, Dauriz M, Laroche C, et al. In‐hospital and 1‐year mortality associated with diabetes in patients with acute heart failure: results from the ESC‐HFA Heart Failure Long‐Term Registry. Eur J Heart Failure 2017; 19(1):54–65.

Liebkind R, Gordin D, Strbian D, et al. Diabetes and intracerebral hemorrhage: baseline characteristics and mortality. Eur J Neurol 2018;25(6):825–32.

Robbins TD, Keung SLC, Sankar S, Randeva H, Arvanitis T. Risk factors for readmission of inpatients with diabetes: a systematic review. J Diabetes Complications 2019;33(5):398–405.

Rubin DJ, Golden SH, McDonnell ME, Zhao H. Predicting readmission risk of patients with diabetes hospitalized for cardiovascular disease: a retrospective cohort study. J Diabetes Complications 2017;31(8):1332–9.

Connolly V, Unwin N, Sherriff P, Bilous R, Kelly W. Diabetes prevalence and socioeconomic status: a population based study showing increased prevalence of type 2 diabetes mellitus in deprived areas. J Epidemiol Community Health 2000;54(3):173–7.

Jotkowitz AB, Rabinowitz G, Segal AR, Weitzman R, Epstein L, Porath A. Do patients with diabetes and low socioeconomic status receive less care and have worse outcomes? A national study. Am J Med 2006;119(8):665–9.

Saydah SH, Imperatore G, Beckles GL. Socioeconomic status and mortality: contribution of health care access and psychological distress among US adults with diagnosed diabetes. Diabetes Care 2013;36(1):49–55.

Carstairs V. Deprivation indices: their interpretation and use in relation to health. J Epidemiol Community Health 1995;49(Suppl 2):S3–S8.

Kim H-Y. Statistical notes for clinical researchers: assessing normal distribution (2) using skewness and kurtosis. Restor Dent Endod 2013;38(1):52–4.

Robbins T, Keung SNLC, Sankar S, Randeva H, Arvanitis TN. Application of standardised effect sizes to hospital discharge outcomes for people with. diabetes. BMC Med Inform Decis Mak 2020;20:150.

Suwannaphant K, Laohasiriwong W, Puttanapong N, Saengsuwan J, Phajan T. Association between socioeconomic status and diabetes mellitus: the National Socioeconomics Survey, 2010 and 2012. J Clin Diagn Res 2017; 11(7):LC18.






Original Research

Most read articles by the same author(s)